Neutrophil CD64 for monitoring the activity of nontuberculous mycobacteria infection in patients with rheumatoid arthritis. 2014

Akiko Komiya, and Toshihiro Matsui, and Koichiro Horie, and Hidefumi Fukuda, and Shinichi Nogi, and Kanako Iwata, and Hirotaka Tsuno, and Hideki Ogihara, and Hidekazu Futami, and Tatsuoh Ikenaka, and Misato Kawakami, and Hiroshi Furukawa, and Atsushi Hashimoto, and Shigeto Tohma
Department of Clinical Laboratory, Sagamihara National Hospital, National Hospital Organization , Kanagawa , Japan.

OBJECTIVE To evaluate the utility of neutrophil CD64 as a marker for monitoring the activity of nontuberculous mycobacteria (NTM) infection in patients with rheumatoid arthritis (RA). METHODS We compared neutrophil CD64 expression in nine RA patients with NTM infection in the active and inactive phase of NTM disease chronologically. "Active phase" was here defined as present in patients admitted to hospital to receive intensive treatment for NTM, as well as outpatients with an infectious episode showing positive acid- and alcohol-fast bacillus (AFB) staining of sputa (Grade 2-3) who needed to start treatment for NTM with a multiple antibiotics regimen. The cut-off value for CD64 positivity was 2000 molecules/cell. RESULTS Neutrophils from patients with active-phase NTM infection expressed high levels of CD64 with a mean ± SEM of 7335 ± 784 molecules/cell. However, during the inactive phase of disease, this was significantly lower (1481 ± 103 molecules/cell, p < 0.001). The sensitivity and specificity of neutrophil CD64 to detect active-phase NTM infection was 96.3% and 84.6%, respectively. Expression of neutrophil CD64 was not affected by disease activity of the RA itself. CONCLUSIONS Neutrophil CD64 is useful for monitoring disease activity in NTM infection of patients with RA.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009165 Mycobacterium Infections, Nontuberculous Infections with nontuberculous mycobacteria (atypical mycobacteria): M. kansasii, M. marinum, M. scrofulaceum, M. flavescens, M. gordonae, M. obuense, M. gilvum, M. duvali, M. szulgai, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. xenopi (littorale), M. ulcerans, M. buruli, M. terrae, M. fortuitum (minetti, giae), M. chelonae, M. leprae. Mycobacterium Infections, Atypical,Atypical Mycobacterial Infection, Disseminated,Atypical Mycobacterial Infection, Familial Disseminated,Atypical Mycobacteriosis, Familial,Atypical Mycobacteriosis, Familial Disseminated,Atypical Mycobacterium Infections,Infections, Atypical Mycobacterium,Mycobacterium abscessus Infection,Atypical Mycobacterium Infection,Familial Atypical Mycobacterioses,Familial Atypical Mycobacteriosis,Infection, Mycobacterium abscessus,Infections, Mycobacterium abscessus,Mycobacterioses, Familial Atypical,Mycobacteriosis, Familial Atypical,Mycobacterium Infection, Atypical,Mycobacterium Infection, Nontuberculous,Mycobacterium abscessus Infections,Nontuberculous Mycobacterium Infection,Nontuberculous Mycobacterium Infections
D009170 Nontuberculous Mycobacteria So-called atypical species of the genus MYCOBACTERIUM that do not cause tuberculosis. They are also called tuberculoid bacilli, i.e.: M. abscessus, M. buruli, M. chelonae, M. duvalii, M. flavescens, M. fortuitum, M. gilvum, M. gordonae, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. kansasii, M. marinum, M. obuense, M. scrofulaceum, M. szulgai, M. terrae, M. ulcerans, M. xenopi. Atypical Mycobacteria,Mycobacteria, Atypical,Mycobacterium duvalii,Mycobacterium flavescens,Mycobacterium gilvum,Mycobacterium gordonae,Mycobacterium obuense,Mycobacterium szulgai,Mycobacterium terrae,Mycolicibacter terrae,Mycolicibacterium duvalii,Mycolicibacterium flavescens,Mycolicibacterium gilvum,Mycolicibacterium obuense,Tuberculoid Bacillus,Atypical Mycobacterium,Mycobacterium, Atypical,Non-Tuberculous Mycobacteria,Nontuberculous Mycobacterium
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity

Related Publications

Akiko Komiya, and Toshihiro Matsui, and Koichiro Horie, and Hidefumi Fukuda, and Shinichi Nogi, and Kanako Iwata, and Hirotaka Tsuno, and Hideki Ogihara, and Hidekazu Futami, and Tatsuoh Ikenaka, and Misato Kawakami, and Hiroshi Furukawa, and Atsushi Hashimoto, and Shigeto Tohma
September 2013, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases,
Akiko Komiya, and Toshihiro Matsui, and Koichiro Horie, and Hidefumi Fukuda, and Shinichi Nogi, and Kanako Iwata, and Hirotaka Tsuno, and Hideki Ogihara, and Hidekazu Futami, and Tatsuoh Ikenaka, and Misato Kawakami, and Hiroshi Furukawa, and Atsushi Hashimoto, and Shigeto Tohma
January 1988, The American review of respiratory disease,
Akiko Komiya, and Toshihiro Matsui, and Koichiro Horie, and Hidefumi Fukuda, and Shinichi Nogi, and Kanako Iwata, and Hirotaka Tsuno, and Hideki Ogihara, and Hidekazu Futami, and Tatsuoh Ikenaka, and Misato Kawakami, and Hiroshi Furukawa, and Atsushi Hashimoto, and Shigeto Tohma
January 2023, Radiologia,
Akiko Komiya, and Toshihiro Matsui, and Koichiro Horie, and Hidefumi Fukuda, and Shinichi Nogi, and Kanako Iwata, and Hirotaka Tsuno, and Hideki Ogihara, and Hidekazu Futami, and Tatsuoh Ikenaka, and Misato Kawakami, and Hiroshi Furukawa, and Atsushi Hashimoto, and Shigeto Tohma
December 1996, Seminars in respiratory infections,
Akiko Komiya, and Toshihiro Matsui, and Koichiro Horie, and Hidefumi Fukuda, and Shinichi Nogi, and Kanako Iwata, and Hirotaka Tsuno, and Hideki Ogihara, and Hidekazu Futami, and Tatsuoh Ikenaka, and Misato Kawakami, and Hiroshi Furukawa, and Atsushi Hashimoto, and Shigeto Tohma
March 2011, Emerging infectious diseases,
Akiko Komiya, and Toshihiro Matsui, and Koichiro Horie, and Hidefumi Fukuda, and Shinichi Nogi, and Kanako Iwata, and Hirotaka Tsuno, and Hideki Ogihara, and Hidekazu Futami, and Tatsuoh Ikenaka, and Misato Kawakami, and Hiroshi Furukawa, and Atsushi Hashimoto, and Shigeto Tohma
December 2006, The Journal of rheumatology,
Akiko Komiya, and Toshihiro Matsui, and Koichiro Horie, and Hidefumi Fukuda, and Shinichi Nogi, and Kanako Iwata, and Hirotaka Tsuno, and Hideki Ogihara, and Hidekazu Futami, and Tatsuoh Ikenaka, and Misato Kawakami, and Hiroshi Furukawa, and Atsushi Hashimoto, and Shigeto Tohma
March 2022, Scientific reports,
Akiko Komiya, and Toshihiro Matsui, and Koichiro Horie, and Hidefumi Fukuda, and Shinichi Nogi, and Kanako Iwata, and Hirotaka Tsuno, and Hideki Ogihara, and Hidekazu Futami, and Tatsuoh Ikenaka, and Misato Kawakami, and Hiroshi Furukawa, and Atsushi Hashimoto, and Shigeto Tohma
May 2022, Scientific reports,
Akiko Komiya, and Toshihiro Matsui, and Koichiro Horie, and Hidefumi Fukuda, and Shinichi Nogi, and Kanako Iwata, and Hirotaka Tsuno, and Hideki Ogihara, and Hidekazu Futami, and Tatsuoh Ikenaka, and Misato Kawakami, and Hiroshi Furukawa, and Atsushi Hashimoto, and Shigeto Tohma
December 2021, Hematology (Amsterdam, Netherlands),
Akiko Komiya, and Toshihiro Matsui, and Koichiro Horie, and Hidefumi Fukuda, and Shinichi Nogi, and Kanako Iwata, and Hirotaka Tsuno, and Hideki Ogihara, and Hidekazu Futami, and Tatsuoh Ikenaka, and Misato Kawakami, and Hiroshi Furukawa, and Atsushi Hashimoto, and Shigeto Tohma
March 2015, Clinics in chest medicine,
Copied contents to your clipboard!